Beta-adrenoceptor and epoprostenol (prostacyclin) responsiveness of lymphocytes in migraine patients
Open Access
- 1 June 1984
- journal article
- research article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 60 (704) , 391-393
- https://doi.org/10.1136/pgmj.60.704.391
Abstract
Summary: Beta-adrenoceptor blocking drugs are of prophylactic value in some patients with migraine. Beta-adrenoceptor responsiveness as measured by lymphocyte cAMP responsiveness to isoprenaline has, therefore, been compared in ten untreated classical migraine patients and ten matched non-migraine control subjects. Lymphocyte responsiveness to epoprostenol (prostacyclin, PGI2) was also compared. No difference in response to either agent was found between the two groups. A generalized abnormality of beta-adrenoceptor function does not appear to be present in classical migraine, but a defect localized to specific vascular regions cannot be excluded.This publication has 4 references indexed in Scilit:
- Beta-adrenoceptor involvement in tremor production: possible defects in essential tremorPublished by Springer Nature ,1984
- BETA-BLOCKING DRUGS INCREASE RESPONSIVENESS TO PROSTACYCLIN IN HYPERTENSIVE PATIENTSThe Lancet, 1982
- β-Adrenoceptor Blockade and MigraineCephalalgia, 1982
- A simple and sensitive saturation assay method for the measurement of adenosine 3′:5′-cyclic monophosphateBiochemical Journal, 1971